Opening session
Welcome and Introduction
Silvia C. Formenti, MD Weill Cornell Medical College New York, NY, USA
Jedd Wolchok, MD, PhD Weill Cornell Medical College New York, NY, USA
Three days of scientific discussions, keynote lectures and expert sessions dedicated to radiation therapy, nuclear medicine and anti-tumor immunity.
Download the program September 23–25, 2026 Three-day scientific program
New York, USA Medical scientific meeting
Day 1
2:00 pm – 6:30 pmWednesday, September 23, 2026
Keynote Lecture
Sponsored by TBDTheranostics and Nuclear Medicine
Theranostics: Transforming Diagnosis and Treatment Through Nuclear Medicine
Robert Flavell University of California, San Francisco San Francisco, CA, USA
Main Program
Session I
Supported by TBDRadionuclide Therapy and Anti-Tumor Immunity
Chair: Vikram Bhadrasain, NIH
Phase I/II of a FAP-targeted radiopharmaceutical for sarcomas
John Babich Ratio Therapeutics Boston, MA, USA
Radiopharmaceuticals, dose heterogeneity and anti-tumor immunity
Zachary Morris University of Wisconsin Madison, WI, USA
PARP theranostic and anti-tumor immunity
Sarah Gitto University of Pennsylvania Philadelphia, PA, USA
Selected abstract
Short presentation selected from abstracts
Coffee Break 4:30 pm – 5:00 pm
Session II
Supported by TBDImaging Radiation-Induced Immune Response
Chair: TBD
Radiomics-based imaging of radiation-induced immune modulation
Eric Deutsch Gustave Roussy Paris, France
Visualizing immune dynamics with ImmunoPET
Anna Wu City of Hope Los Angeles, CA, USA
PD-L1 immunoPET for precision neuro-oncology
Gabriela Kramer-Marek Institute for Cancer Research London, UK
Selected abstract
Short presentation selected from abstracts
6:30 pm End of Day 1
Day 2
8:30 am – 8:30 pmThursday, September 24, 2026
Keynote Lecture
Sponsored by TBDMechanisms of Immune Tolerance
Mechanisms of Immune Tolerance: Balancing Immunity and Homeostasis
Julie Magarian Blander Weill Cornell Medicine New York, NY, USA
Session III
Supported by TBDImmune Tolerance Mechanisms: Implications for Radiation Therapy
Chair: TBD
Aging and Immunity
Michael Lotze University of Pittsburgh
Title TBD
Presentation title to be announced
Pier Giuseppe Pelicci Istituto Europeo di Oncologia
Thymus Health and Immune Tolerance
Silvia Formenti Weill Cornell Medicine New York, NY, USA
Astrocyte-tumor co-evolution shapes recurrent, radioresistant glioblastoma
Alexander Pietras Lund University Lund, Sweden
Coffee Break 10:55 am – 11:25 am
Session IV
Supported by TBDImmune Effects of Radiation in the Clinic: Contributions from the ROBIN Centers
Chair: TBD
ImmunoRad ROBIN
Encouse Golden Weill Cornell Medicine New York, NY, USA
Meteor ROBIN
Julie Schwarz Washington University in St. Louis St. Louis, MO, USA
Kids ROBIN
Jonathan Schoenfeld Harvard Medical School Boston, MA, USA
GenRad ROBIN
Timothy Chan Cleveland Clinic Cleveland, OH, USA
OligoMet ROBIN
Chad Tang MD Anderson Houston, TX, USA
Discussion
Questions & Answers
Lunch Break 1:15 pm – 2:15 pm
Session V
Supported by TBDHow to Harness RT to Potentiate an Immune Response
Chair: TBD
Radiation therapy and immunotherapy: what we have learned in the clinic
Sana Karam Washington University in St. Louis St. Louis, MO, USA
Radiation and Metabolism – Lung
Arta Monjazeb University of California, Davis Davis, CA, USA
Update on the P-RAD trial in breast cancer
Gaorav Gupta University of North Carolina at Chapel Hill Chapel Hill, NC, USA
Coffee Break 3:30 pm – 4:00 pm
Session VI
Supported by TBDNormal Tissue vs. Tumor Response to Radiation
Chair: TBD
Immune effect of FLASH
Constantino Koumenis University of Pennsylvania Philadelphia, PA, USA
Update on RadScopal
James Welsh MD Anderson Houston, TX, USA
Reversing tumor immune tolerance with FLASH radiation and lipid signaling
Yi Fan University of Pennsylvania Philadelphia, PA, USA
Selected abstract
Short presentation selected from abstracts
Panel Discussion
Supported by TBDIntratumoral Immunotherapy with Radiation Therapy to Enhance Anti-Tumor Immunity
5:30 pm – 6:30 pm
Sana Karam Washington University in St. Louis St. Louis, MO, USA
Howard Kaufman Ankyra Therapeutics Cambridge, MA, USA
Aisha Hasan Johnson & Johnson
6:30 pm to 8:30 pm
Networking Poster Session
Scientific posters, discussions and networking.
Day 3
8:30 am – 9:00 pmFriday, September 25, 2026
Keynote Lecture
Sponsored by TBDAdaptive Tumor Response to Radiation
Adaptive tumor response to radiation: From damage signaling to therapy resistance
Ralph Weichselbaum University of Chicago Chicago, IL, USA
Session VII
Supported by TBDInnate Immunity and Radiation Therapy
Chair: TBD
Macrophages and Radiation
Nir Ben Chetrit Weill Cornell Medicine New York, NY, USA
Mitophagy at the crossroads of innate immunity and radiation response
Lorenzo Galluzzi Fox Chase Cancer Center Philadelphia, PA, USA
Type I interferon in Radiation Therapy: Friend or Foe?
Andy Minn Memorial Sloan Kettering New York, NY, USA
Selected abstract
Short presentation selected from abstracts
Selected abstract
Short presentation selected from abstracts
Coffee Break 11:10 am – 11:40 am
Session VIII
Supported by TBDThe Microbiome in the Context of Radiation
Chair: TBD
Gut microbiome and radiation: shaping the immune response
Marine Fidelle Gustave Roussy Paris, France
Regulation of tumor response to radiation by commensal bacteria and fungi
Stephen Shiao Cedars-Sinai Los Angeles, CA, USA
Targeted gut microbiome interventions boost antitumor immunity during SBRT
Andrea Facciabene University of Pennsylvania Philadelphia, PA, USA
Lunch Break 12:55 pm – 2:30 pm
Session IX
Supported by TBDRole of Radiation in Cell Therapy
Chair: TBD
Title TBD
Presentation title to be announced
Chandan Guha Albert Einstein College of Medicine New York, NY, USA
Low-dose RT and CAR T cells
Monica Guzman Weill Cornell Medicine New York, NY, USA
Title TBD
Presentation title to be announced
Bo Lu University of Missouri Columbia, MO, USA
Selected abstract
Short presentation selected from abstracts
Panel Discussion
Supported by TBDArtificial Intelligence in Radiation and Immunotherapy
3:55 pm – 5:00 pm
James Welsh MD Anderson Houston, TX, USA
Akshay Nanduri Onc AI Waterloo, ON, Canada
Joe Deasy Memorial Sloan Kettering New York, NY, USA
Aaron Berliner Weill Cornell Medicine New York, NY, USA
5:00 pm End of Scientific Program
```
© IMMUNORAD 2026®, Créé par CED-WEB
